MDR.AU · MedAdvisor Limited

-

Please sign in to comment on MDR.AU

1 Comment

Admin

3 years, 7 months ago

MedAdvisor Limited is currently in a long term downtrend where the price is trading 12.4% below its 200 day moving average.

From a valuation standpoint, the stock is 98.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.0.

MedAdvisor Limited's total revenue rose by 189.4% to $13M since the same quarter in the previous year.

Its net income has dropped by 47.8% to $-8M since the same quarter in the previous year.

Finally, its free cash flow grew by 54.9% to $-1M since the same quarter in the previous year.

Based on the above factors, MedAdvisor Limited gets an overall score of 3/5.

Industry	Health Information Services
Sector	Healthcare
ISIN	AU000000MDR6
CurrencyCode	AUD
Exchange	AU

Dividend Yield	0.0%
Market Cap	136M
Target Price	0.39
PE Ratio	0.0
Beta	0.58

ABOUT

MedAdvisor Limited

MedAdvisor Limited, together with its subsidiaries, develops and delivers software in Australia, the United States, the United Kingdom, and Asia. The company provides MedAdvisor, a medication and adherence platform that focuses on improving health outcomes by connecting health professionals with their patients using technology and enhancing medication adherence through health programs; THRiV, an intelligent digital adherence solution; and GuildCare, a cloud-based platform that offers healthcare solutions and medicines information for consumers, health professionals, and other partners. MedAdvisor Limited was incorporated in 2010 and is headquartered in Camberwell, Australia.

MDR.AU · MedAdvisor Limited

-

MedAdvisor Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest MedAdvisor Limited using a moving average strategy